Single-Cell Multiomics Market Size Worth USD 6.18 Billion by 2034 | CAGR: 19.49%

The single-cell multiomics market is expected to reach USD 6.18 billion by 2034, according to a new study by Polaris Market Research. The report “Single-Cell Multiomics Market Size, Share, Trends, & Industry Analysis Report By Technology (Droplet-Based, Combinatorial Indexing, Direct Multiomics Capture, Sequencing-Based Capture), By Application, By End User, By Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Single-cell multiomicsis moving beyond the initial objective of measuring more molecular information per cell. The commercial opportunity is increasingly tied to how effectively different molecular layers can be linked, processed, and translated into usable biological insight. Researchers are combining transcriptomic, genomic, epigenomic, proteomic, and immune-receptor information to examine cellular states that cannot be adequately resolved through single-layer assays.

“The competitive question in single-cell multiomics is changing. Generating another molecular layer is no longer enough. Researchers need linked measurements that can answer a specific biological question, at a practical scale and without creating an unmanageable downstream workflow. Platforms that improve the connection between molecular depth, throughput, and experimental flexibility are likely to have the strongest commercial position as adoption moves beyond specialist research groups." — Polaris Market Research & Consulting, Senior Life Sciences Analyst

Single Cell Multiomics Market Investment Signals 2026

Investment Theme	Market Signal	Business Implication
High-throughput Perturb-seq	Single-cell perturbation experiments are being scaled to millions of cells	Expands the role of single-cell platforms in functional genomics and drug discovery
Direct multiomics	Vendors are developing workflows that link multiple molecular layers from the same cell	Creates opportunities for differentiated assay architectures and higher-value consumables
Multistep single-cell processing	Semi-Permeable Capsule technology is enabling sequential processing while retaining cell compartments	Broadens the range of workflows that can be performed at single-cell resolution
Service-provider expansion	Certified service networks are increasing access to single-cell technologies without direct instrument ownership	Lowers adoption barriers for academic and biotechnology laboratories
AI-ready biological datasets	Large-scale multimodal datasets are becoming more valuable for computational biology and AI applications	Increases demand for structured, high-dimensional single-cell datasets and analytical software

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Single-Cell Multiomics Market Report

Key Factors Driving Single-cell Multiomics Industry in 2026

High-throughput Perturbation Is Expanding the Commercial Role of Single-cell Analysis

Single-cell analysis is increasingly used to test biological hypotheses rather than simply characterize cellular populations. Perturb-seq combines genetic perturbation with single-cell readouts, allowing researchers to observe how specific interventions alter cellular states.

Direct and Multistep Multiomics Are Creating Alternative Platform Architectures

The market is witnessing competition around how multiomics experiments are physically performed. Conventional droplet systems offer substantial throughput but are difficult to use for complex sequential workflows that require repeated washing, buffer exchange, enzymatic reactions, or additional processing.

Service Networks Are Lowering the Entry Barrier for Single-cell Technologies

The market is expanding through outsourced access. Laboratories do not always need to purchase instruments or establish complete single-cell workflows internally. Certified service providers perform sample preparation, sequencing, and analysis on behalf of customers, allowing researchers to test new technologies before committing to larger infrastructure investments.

Single Cell Multi-Omics Market Report Highlights

North America led the global single cell multiomics market share by holding 41.28% in 2025. The dominance is driven by the concentration of platform developers and research institutions across the region.
The Asia Pacific market is expected to exhibit a CAGR of 23.16% during the projected year. The regional market growth is fueled by its rising pharmaceutical research activities and national genomics initiatives.
Droplet-based segment accounted for the largest market share of 57.62% in 2025. This is due to their established commercial track record and broad academic application.
Oncology held the largest share of 36.18% in 2025. It is attributed to established single-cell research activities for cancer management.
A few market players are 10x Genomics, Inc., Agilent Technologies, Inc., Akoya Biosciences, Inc., Atrandi Biosciences, Becton, Dickinson and Company, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, Dolomite Bio, Illumina, Inc., Mission Bio, Inc., Miltenyi Biotec B.V. & Co. KG, NanoString Technologies, Inc., Olink Holding AB, Pacific Biosciences of California, Inc., Parse Biosciences, Inc., QIAGEN N.V., Singular Genomics Systems, Inc., Standard BioTools Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., and Vizgen, Inc.

Single-Cell Multiomics Market report based on technology, application, end use, and region:

By Technology Outlook (Revenue, USD Billion, 2021–2034)

Droplet-Based
Combinatorial Indexing
Direct Multiomics Capture
Sequencing-Based Capture

By Application Outlook (Revenue, USD Billion, 2021–2034)

Oncology
Immunology
Drug Discovery
Target Validation

By End User Outlook (Revenue, USD Billion, 2021–2034)

Academic and Government Institutions
Pharmaceutical and Biotechnology Companies

By Regional Outlook (Revenue, USD Billion, 2021–2034)

North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Taiwan
- Australia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa